Providing excellent care and the latest research to help patients
The Brain Tumour Foundation of Canada estimates that 27 Canadians a day are diagnosed with a brain tumour and 55,000 are living with one. This Brain Tumour Awareness Week we recognize the toll this disease takes on patients and the work being done to improve their quality of life.
Healthy Brains for Healthy Lives (HBHL) is pleased to announce the second round of its Innovative Ideas competition. The Innovative Ideas Program supports the exploration of novel ideas with the potential for breakthrough science. At least 8 projects will be awarded up to $200,000 over 2 years.
The deadline for submitting a Letter of Intent (LOI) is November 23, 2018, 5:00 pm EST
Consult the program description for more details.
Young scientists in the field of cognitive neuroscience got expert guidance and hands-on training in machine learning at a workshop organized by Healthy Brains for Healthy Lives (HBHL) and the McGill Centre for Integrative Neuroscience (MCIN), from October 15 to 17.
Lesson number one: Beware of the buzz.
Source: Cell Metabolism
New research suggests that higher-level brain functions have a major role in losing weight. In a study among 24 participants at a weight-loss clinic, those who achieved greatest success in terms of weight loss demonstrated more activity in the brain regions of the lateral prefrontal cortex associated with self-control. The results of the study were published in Cell Metabolism on October 18.
Brain cancer begins in stem cells, targeting them may prevent tumour growth
Researchers at the Montreal Neurological Institute and Hospital (The Neuro) have found an exciting new way of treating brain cancer.
Late stage brain cancer cells are heterogeneous — they differ down to the molecular level. This makes developing treatments at this stage difficult, because a drug that may be effective against one cell may not be effective against another.
Carriers at higher risk of developing neurodegenerative disease
A team of Canadian scientists, including researchers at the Montreal Neurological Institute and Hospital (The Neuro) has discovered the first French-Canadian founder mutation gene linked to synucleinopathies, a group of neurodegenerative diseases that includes Parkinson’s disease (PD), dementia with Lewy-Bodies (DLB) and multiple system atrophy (MSA).
Plasticity is enhanced but dysregulated in the aging brain
They say you can’t teach old dogs new tricks, but new research shows you can teach an old rat new sounds, even if the lesson doesn’t stick very long.
When it comes to weight gain, the problem may be mostly in our heads, and our genes
Clinicians should consider how the way we think can make us vulnerable to obesity, and how obesity is genetically intertwined with brain structure and mental performance, according to new research.
Scientist Brenda Milner, born in 1918, pioneered memory research
Pioneering neuropsychologist Brenda Milner turns 100 today. Milner made groundbreaking discoveries in the field of human memory.
Born on July 15, 1918 in Manchester, UK, Milner came to Canada in 1944 and finished a PhD at McGill University under psychologist Donald Hebb in 1952, moving on to a tenured position studying epilepsy patients at the Montreal Neurological Institute and Hospital (The Neuro).
Technique can be used to better categorize patients with neurological disease, according to their therapeutic needs
Personalized medicine – delivering therapies specially tailored to a patient’s unique physiology – has been a goal of researchers and doctors for a long time. New research provides a way of delivering personalized treatments to patients with neurological disease.
Finding is key for future treatment and earlier diagnosis
Scientists at the Montreal Neurological Institute and Hospital (The Neuro) of McGill University have used a unique approach to track brain degeneration in Alzheimer’s disease, uncovering a pathway through which degeneration spreads from one region to another.
Montreal — In a study published in Stem Cell Reports, a McGill team of scientists led by Dr. Carl Ernst, researcher at the Douglas Hospital Research Centre, revealed a molecular mechanism that may play a role in the development of autism.
Endowment to bolster big-data research and help establish Global Brain Consortium at Ludmer Centre
Discovery will aid diagnosis and development of treatments
Scientists at the Montreal Neurological Institute and Hospital (The Neuro) and McGill University have identified novel genes associated with a specific form of schizophrenia.
Schizophrenia is a major psychiatric illness affecting one per cent of the population worldwide. Patients suffering from schizophrenia present delusions, hallucinations, abnormal behavior, impairment in daily life and cognitive deficits. Current treatments are insufficient in addressing all of these symptoms.
Award-winning unit will add 10 new beds this year
Stroke is the third-leading cause of death in Canada. Each year, some 14,000 Canadians die as a result of a stroke.
June is Stroke Awareness Month, a time to spread awareness of the causes and effects of stroke as well as its treatment.
